Visceral adiposity and insulin resistance are independent predictors of the presence of non-cirrhotic NAFLD-related portal hypertension. (Q51394345)

4 April 2018

title

Visceral adiposity and insulin resistance are independent predictors of the presence of non-cirrhotic NAFLD-related portal hypertension. (English)

1 reference

4 April 2018

1 reference

7

1 reference

4 April 2018

author name string

S Francque

1

1 reference

4 April 2018

A Verrijken

2

1 reference

4 April 2018

I Mertens

3

1 reference

4 April 2018

G Hubens

4

1 reference

4 April 2018

E Van Marck

5

1 reference

4 April 2018

P Pelckmans

6

1 reference

4 April 2018

L Van Gaal

8

1 reference

4 April 2018

language of work or name

English

0 references

publication date

27 July 2010

1 reference

4 April 2018

International Journal of Obesity

published in

1 reference

4 April 2018

volume

35

1 reference

4 April 2018

page(s)

270-278

1 reference

4 April 2018

issue

2

1 reference

4 April 2018

https://scigraph.springernature.com/pub.10.1038/ijo.2010.134

exact match

0 references

cites work

Nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

Fatty liver in liver transplantation and surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

Hepatic steatosis as a potential risk factor for major hepatic resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

Regeneration of liver with marked fatty change following partial hepatectomy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

Role of inflammation in nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

In vivo demonstration of impaired microcirculation in steatotic human liver grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

Non-alcoholic steatohepatitis induces non-fibrosis-related portal hypertension associated with splanchnic vasodilation and signs of a hyperdynamic circulation in vitro and in vivo in a rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

Pathogenesis of portal hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

Portal hypertension: from pathophysiology to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

Aminopyrine breath test in the prognostic evaluation of patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

The metabolic syndrome--a new worldwide definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

Evaluation of abnormal liver-enzyme results in asymptomatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

Updated definitions of healthy ranges for serum alanine aminotransferase levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

Diagnosis of fatty liver disease: is biopsy necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

Nonalcoholic fatty liver disease in patients investigated for elevated liver enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

Motion - all patients with NASH need to have a liver biopsy: arguments for the motion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

Review article: the evolving role of liver biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

Transjugular liver biopsy--indications, adequacy, quality of specimens, and complications--a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

Measurement of portal pressure: when, how, and why to do it.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

Measurement of portal pressure and its role in the management of chronic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

Treatment of obesity: need to focus on high risk abdominally obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

Body mass index as a predictor of hepatic steatosis in living liver donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

Body fat distribution, relative weight, and liver enzyme levels: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

Adipose tissue as an endocrine organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

Fatty liver and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

Insulin resistance: a metabolic pathway to chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

Visceral adipose tissue and inflammation correlate with elevated liver tests in a cohort of overweight and obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

Mechanisms of ischemic injury are different in the steatotic and normal rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

7 January 2021

Prevalence of and risk factors for hepatic steatosis in Northern Italy

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

7 January 2021

Nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

7 January 2021

Adipokines and cytokines in non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

7 January 2021

Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

7 January 2021

Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

7 January 2021

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.134

7 January 2021

Identifiers

DOI

10.1038/IJO.2010.134

1 reference

4 April 2018

PubMed ID

20661251

1 reference

4 April 2018